External Source

Cd33-tim3 Dual Car T-cells Enhance Specificity Of Aml Treatment

2023 1:43
Synopsis
Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, discusses the three main approaches and ...

You Might Also Like

Early CAR-T Results for CD33 Positive AML Using PRGN-3006 Ultracar-T | David Sallman | ASH 2021 #AML 2:26
Early Car-t Results For Cd33 Positive Aml Using Prgn-3006 Ul...
2021
DARIC33 CAR T-cells in AML 2:38
Daric33 Car T-cells In Aml
2021
Engineering multi-antigenic CAR T-cells for AML 2:03
Engineering Multi-antigenic Car T-cells For Aml
2021
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody 1:42
Harnessing T-cells In Acute Leukemia And An Anti-cd33/cd3 Bi...
2018
An update on CAR-T therapy in AML: challenges & emerging strategies 2:23
An Update On Car-t Therapy In Aml: Challenges & Emerging Str...
2022
IL3-zetakine coupled to a CD33 costimulatory receptor as a dual-targeting CAR approach in AML 1:27
Il3-zetakine Coupled To A Cd33 Costimulatory Receptor As A D...
2023
First-in-human CLL1-CD33 compound CAR T-cells for AML 7:11
First-in-human Cll1-cd33 Compound Car T-cells For Aml
2018
CD33 T cell recruiting antibody constructs for treatment of relapsed refractory AML 5:50
Cd33 T Cell Recruiting Antibody Constructs For Treatment Of ...
2019
AMG 673: novel half-life extended anti-CD33/CD3 BiTE in R/R AML 2:23
Amg 673: Novel Half-life Extended Anti-cd33/cd3 Bite In R/r ...
2020
Actimab for CD33 Expressing Hematologic Malignancies | Complete Presentation 49:57
Actimab For Cd33 Expressing Hematologic Malignancies | Compl...
2021
Dr. Ravandi on Targeting CD33 in Relapsed/Refractory AML 1:30
Dr. Ravandi On Targeting Cd33 In Relapsed/refractory Aml
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.